News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Zhou Rong
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $44.205, valued at
$442.1k
Exercised 10,000 options to buy
@ $14.4, valued at
$144k
|
|
| 05/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/20/2023 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,283 shares
@ $37.6, valued at
$85.8k
Paid exercise price by delivering 1,901 shares
@ $36.29, valued at
$69k
|
|
| 03/17/2023 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 2,057 shares
@ $36.84, valued at
$75.8k
|
|
| 03/08/2023 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Granted 15,129 shares
@ $0
Granted 31,882 options to buy
@ $35.13, valued at
$1.1M
|
|
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 7,000 shares
@ $26.77, valued at
$187.4k
Exercised 7,000 options to buy
@ $10.93, valued at
$76.5k
|
|
| 01/11/2022 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 10,677 shares
@ $24.9628, valued at
$266.5k
Sold 10,251 shares
@ $25.7688, valued at
$264.2k
Exercised 14,000 options to buy
@ $10.93, valued at
$153k
|
|
| 11/12/2021 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 7,813 shares
@ $21.67, valued at
$169.3k
Exercised 7,813 options to buy
@ $10.48, valued at
$81.9k
|
|
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2021 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 6,000 shares
@ $20.87, valued at
$125.2k
Exercised 6,000 options to buy
@ $10.48, valued at
$62.9k
|
|
| 07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2020 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 13,163 shares
@ $18.8162, valued at
$247.7k
Sold 9,806 shares
@ $19.19, valued at
$188.2k
Exercised 11,082 options to buy
@ $11.41, valued at
$126.4k
Exercised 8,918 options to buy
@ $11.41, valued at
$101.8k
|
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 204 shares
@ $19.82, valued at
$4k
|
|
| 05/07/2019 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 9,600 shares
@ $22.76, valued at
$218.5k
Exercised 9,600 options to buy
@ $20.26, valued at
$194.5k
|
|
| 03/28/2019 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 814 shares
@ $20.54, valued at
$16.7k
|
|
| 03/18/2019 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Granted 10,133 shares
@ $0
Paid exercise price by delivering 1,179 shares
@ $20.23, valued at
$23.9k
Paid exercise price by delivering 1,553 shares
@ $20.23, valued at
$31.4k
Paid exercise price by delivering 1,510 shares
@ $20.23, valued at
$30.5k
Granted 22,541 options to buy
@ $20.23, valued at
$456k
|
|
| 03/04/2019 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 3,200 shares
@ $25, valued at
$80k
Exercised 3,200 options to buy
@ $20.26, valued at
$64.8k
|
|
| 03/04/2019 |
4/A
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Exercised 3,200 options to buy
@ $20.26, valued at
$64.8k
|
|
| 02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 1,089 shares
@ $22, valued at
$24k
|
|
| 11/13/2018 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Sold 1,084 shares
@ $20, valued at
$21.7k
Sold 1,089 shares
@ $21, valued at
$22.9k
|
|
| 06/18/2018 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 134 shares
@ $16.88, valued at
$2.3k
|
|
| 03/28/2018 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 535 shares
@ $18.61, valued at
$10k
|
|
| 03/20/2018 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,128 shares
@ $19.91, valued at
$22.5k
Paid exercise price by delivering 969 shares
@ $19.91, valued at
$19.3k
|
|
| 03/16/2018 |
4
| Zhou Rong (EVP, Production Center) has filed a Form 4 on Amphastar Pharmaceuticals, Inc.|
Txns:
| Granted 8,969 shares
@ $0
Granted 20,827 options to buy
@ $19.79, valued at
$412.2k
|
|
|
|
|